{"url_path":"/sec/vida/10-q/2026/item-2","section_key":"item-2","section_title":"Item 2 Unregistered Sales of Equity Securities and Use of Proceeds.**","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-06-26","source_url":"https://www.sec.gov/Archives/edgar/data/1973062/0001493152-26-030343-index.html","accession_number":"0001493152-26-030343","cik":"0001973062","ticker":"VIDA","issuer_name":"VIDA Global Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1973062/0001493152-26-030343-index.html","primary_entity_key":"0001973062","primary_entity_name":"VIDA Global Inc."},"word_count":652,"has_tables":true,"body_markdown":"**Item\n2. Unregistered Sales of Equity Securities and Use of Proceeds.**\n\n \n\n*Recent\nSales of Unregistered Equity Securities*\n\n \n\nFrom\nJanuary 1, 2026 to (but not including) May 21, 2026 (the date of the filing of our registration statement on Form S-8, File No. 333-296093),\nwe granted to our non-employee directors an aggregate of 657,808 shares of our Class A common stock upon the vesting of restricted stock\nawards under our 2022 Equity Incentive Plan.\n\n \n\nNone\nof the foregoing transactions involved any underwriters, underwriting discounts or commissions, or any public offering. The issuances\nof the securities described above were deemed to be exempt from registration under Rule 701 promulgated under the Securities Act, as\ntransactions under compensatory benefits plans and contracts relating to compensation, or under Section 4(a)(2) of the Securities Act\nas a transaction by an issuer not involving a public offering.\n\n \n\nOn\nMay 18, 2026, we issued to The Benchmark Company, LLC or its designees warrants to purchase up to a total of 187,500 shares of our Class\nA common stock in connection with the IPO and on May 27, 2026, we issued to The Benchmark Company, LLC or its designees warrants to purchase\nup to a total of 15,625 additional shares of our Class A common stock pursuant to the underwriter’s partial exercise of its over-allotment\noption in connection with the IPO (collectively, the “Representative’s Warrants”). The Representative’s Warrants\nare exercisable at $4.80 per share, are initially exercisable on November 14, 2026, and will expire on May 14, 2031. The issuance of\nthe Representative’s Warrants was deemed to be exempt from registration under Section 4(a)(2) of the Securities Act as a transaction\nby an issuer not involving a public offering.\n\n* *\n\n*Use\nof Proceeds*\n\n* *\n\nOn\nMay 18, 2026, we completed our IPO in which we registered and sold an aggregate of 3,750,000 shares of our Class A common stock. The\nshares of Class A common stock sold in the IPO were registered under the Securities Act pursuant to our registration statement on Form\nS-1, as amended (File No. 333-294868), and our registration statement on Form S-1 (File No. 333-295916) (collectively, the “IPO\nRegistration Statement”), which each went effective on May 14, 2026. Our shares of Class A common stock were sold at an initial\npublic offering price of $4.00 per share, which generated aggregate gross proceeds of $15.0 million. The Benchmark Company, LLC acted\nas the underwriter for the IPO.\n\n \n\n69\n\n \n\n \n\nWe\nreceived net proceeds of $12.5 million, net of underwriting discounts and commissions and offering expenses payable by us. No payments\nfor such expenses were made directly or indirectly to (i) any of our officers or directors or their associates, (ii) any persons owning\n10% or more of any class of our equity securities, or (iii) any of our affiliates. We intend to use the net proceeds from the IPO for\ngeneral corporate purposes, working capital and operating expenses. These general corporate purposes may include partner enablement and\ndistribution infrastructure, additional engineering and customer success capacity to increase deployment throughput, and continued investment\nin automation designed to shorten the path from customer signup to production deployment. We may also use a portion of the net proceeds\nto acquire or invest in businesses, products, services or technologies. However, we do not have binding agreements or commitments for\nany material acquisitions or investments at this time.\n\n \n\nOn\nMay 27, 2026, we issued and sold an additional 312,500 shares of our Class A common stock at a public offering price of $4.00 per share,\nwhich generated aggregate gross proceeds of $1.3 million, pursuant to the underwriter’s partial exercise of its over-allotment\noption granted in connection with our IPO. We received net proceeds of $1.2 million, net of underwriting discounts and commissions and\nexpenses payable by us.\n\n \n\nThere\nhas been no material change in the expected use of the net proceeds from our IPO as described in the prospectus included in the IPO Registration\nStatement."}